State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.32B |
| 2 |
Johnson & Johnson
JNJ
|
+$795M |
| 3 |
Abbott
ABT
|
+$554M |
| 4 |
Hormel Foods
HRL
|
+$518M |
| 5 |
Incyte
INCY
|
+$507M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$1.54B |
| 2 |
STJ
St Jude Medical
STJ
|
+$945M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$762M |
| 4 |
AGN
Allergan plc
AGN
|
+$447M |
| 5 |
Becton Dickinson
BDX
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 13.58% |
| 3 | Healthcare | 13.28% |
| 4 | Industrials | 11.83% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSLR
3226
DELISTED
VIVINT SOLAR, INC.
VSLR
| $962K | ﹤0.01% |
343,493
+18,600
| +6% | +$55.8K |
|
3227
Blue Bird Corp
BLBD
$2.35B
| $960K | ﹤0.01% |
56,011
+900
| +2% | +$15K |
|
|
RGLS
3228
DELISTED
Regulus Therapeutics
RGLS
| $959K | ﹤0.01% |
4,838
+238
| +5% | +$45.3K |
|
3229
Silvercrest Asset Management
SAMG
$79M
| $949K | ﹤0.01% |
71,466
+6,959
| +11% | +$95.1K |
|
|
GSOL
3230
DELISTED
Global Sources Ltd
GSOL
| $949K | ﹤0.01% |
114,983
+21,128
| +23% | +$185K |
|
3231
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$374M
| $942K | ﹤0.01% |
+4,687
| New | +$1.01M |
|
|
SALM
3232
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $942K | ﹤0.01% |
126,817
-6,678
| -5% | -$45.5K |
|
3233
Lipocine
LPCN
$17.5M
| $935K | ﹤0.01% |
14,085
+199
| +1% | +$12.9K |
|
|
BPTH
3234
DELISTED
Bio-Path Holdings Inc
BPTH
| $933K | ﹤0.01% |
283
+12
| +4% | +$43.6K |
|
|
NYRT
3235
DELISTED
New York REIT, Inc.
NYRT
| $925K | ﹤0.01% |
9,542
-552,789
| -98% | -$54.3M |
|
3236
Tempest Therapeutics
TPST
$13.7M
| $903K | ﹤0.01% |
165
+1
| +0.6% | +$4.66K |
|
|
AST
3237
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $901K | ﹤0.01% |
264,944
+38,000
| +17% | +$148K |
|
|
ADVM
3238
DELISTED
Adverum Biotechnologies
ADVM
| $899K | ﹤0.01% |
33,217
+1,090
| +3% | +$31K |
|
3239
Constellium
CSTM
$3.76B
| $899K | ﹤0.01% |
138,295
+2,107
| +2% | +$15K |
|
3240
Diageo
DEO
$49B
| $891K | ﹤0.01% |
7,710
-61,101
| -89% | -$6.86M |
|
3241
Ichor Holdings
ICHR
$2.62B
| $891K | ﹤0.01% |
+44,900
| New | +$754K |
|
|
NAGE
3242
Niagen Bioscience
NAGE
$271M
| $891K | ﹤0.01% |
331,073
+6,062
| +2% | +$17.2K |
|
3243
Lifeway Foods
LWAY
$455M
| $886K | ﹤0.01% |
82,527
-921
| -1% | -$10.1K |
|
|
UCP
3244
DELISTED
UCP, Inc.
UCP
| $882K | ﹤0.01% |
86,994
+6,660
| +8% | +$74K |
|
|
SLAI
3245
DELISTED
SOLAI Ltd ADS
SLAI
| $869K | ﹤0.01% |
926
-4
| -0.4% | -$3.72K |
|
|
CZZ
3246
DELISTED
Cosan Limited
CZZ
| $849K | ﹤0.01% |
99,309
-17,730
| -15% | -$149K |
|
3247
Valhi
VHI
$380M
| $847K | ﹤0.01% |
21,535
-719
| -3% | -$29.2K |
|
3248
Syndax Pharmaceuticals
SNDX
$1.69B
| $841K | ﹤0.01% |
61,221
+2,300
| +4% | +$23.9K |
|
|
CVRS
3249
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $840K | ﹤0.01% |
641,932
+75,000
| +13% | +$61.1K |
|
|
MITL
3250
DELISTED
Mitel Networks Corporation
MITL
| $839K | ﹤0.01% |
121,161
+5,985
| +5% | +$41.8K |
|
Similar funds
State Street's Q1 2017 Portfolio in Review
As of Q1 2017, State Street held 3,741 positions worth $1.12T, up 5.5% from $1.06T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2017: portfolio turnover was 4.1%. State Street opened 76 new positions and exited 78, leaving the 3,741-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q1 2017 buy was Enbridge: 11,436,560 shares worth $479M.
- State Street added most to ExxonMobil in Q1 2017, an estimated $1.32B increase.
- State Street's biggest Q1 2017 reduction was Allergan plc, cutting an estimated $447M.
- State Street fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $1.54B.
- State Street's ten largest holdings make up 15% of its $1.12T portfolio in Q1 2017.
- State Street opened 76 new positions and closed 78 in Q1 2017.
- State Street's portfolio value rose 5.5% quarter-over-quarter to $1.12T.
Based on State Street's 13F filing for Q1 2017, filed 15 May 2017.